Glucagon is required for early insulin-positive differentiation in the developing mouse pancreas.

The embryonic pancreas is thought to develop from pluripotent endodermal cells that give rise to endocrine and exocrine cells. A key guidance mechanism for pancreatic development has previously been found to be epithelial-mesenchymal interaction. Interactions within the epithelium, however, have not been well studied. Glucagon is the earliest peptide hormone present at appreciable levels in the developing pancreatic epithelium (embryonic day [E]-9.5 in mouse). Insulin accumulation begins slightly later (E11 in mouse), followed by a rapid accumulation during the "second wave" of insulin differentiation ( approximately E15). Here we found that blocking early expression and function of glucagon, but not GLP-1, an alternate gene product of preproglucagon mRNA, prevented insulin-positive differentiation in early embryonic (E11) pancreas. These results suggest a novel concept and a key role for glucagon in the paracrine induction of differentiation of other pancreatic components in the early embryonic pancreas.

[1]  P. Gruss,et al.  Pax4 regulatory elements mediate beta cell specific expression in the pancreas , 2001, Mechanisms of Development.

[2]  D. Drucker,et al.  Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice. , 2000, Endocrinology.

[3]  R. Scharfmann.  Control of early development of the pancreas in rodents and humans: implications of signals from the mesenchyme , 2000, Diabetologia.

[4]  P. Herrera,et al.  Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. , 2000, Development.

[5]  S. Bonner-Weir,et al.  Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. , 2000, Diabetes.

[6]  P. Gruss,et al.  Pax genes and the differentiation of hormone-producing endocrine cells in the pancreas , 2000, Mechanisms of Development.

[7]  Jie Zhou,et al.  Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. , 1999, Diabetes.

[8]  B. Ahrén.  Glucagon‐like peptide‐1 (GLP‐1): A gut hormone of potential interest in the treatment of diabetes , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[9]  L. Orci,et al.  Two transgenic approaches to define the cell lineages in endocrine pancreas development , 1998, Molecular and Cellular Endocrinology.

[10]  D. Drucker,et al.  Tissue-specific Expression of Unique mRNAs That Encode Proglucagon-derived Peptides or Exendin 4 in the Lizard* , 1997, The Journal of Biological Chemistry.

[11]  W. Rutter,et al.  Lineage-specific morphogenesis in the developing pancreas: role of mesenchymal factors. , 1996, Development.

[12]  D. D’Alessio,et al.  Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons. , 1996, The Journal of clinical investigation.

[13]  R. Heller,et al.  Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7--36) amide. , 1995, The American journal of physiology.

[14]  J. Slack.  Developmental biology of the pancreas. , 1995, Development.

[15]  D. Smith,et al.  Glucagon-like peptide-1 is a physiological incretin in rat. , 1995, The Journal of clinical investigation.

[16]  G. Gittes.  Studies of Early Events in Pancreatic Organogenesis , 1994, Annals of the New York Academy of Sciences.

[17]  B. Göke,et al.  Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. , 1993, The Journal of biological chemistry.

[18]  D. Hanahan,et al.  Precursor cells of mouse endocrine pancreas coexpress insulin, glucagon and the neuronal proteins tyrosine hydroxylase and neuropeptide Y, but not pancreatic polypeptide. , 1993, Development.

[19]  J. Raufman,et al.  Exendin-4, a new peptide from Heloderma suspectum venom, potentiates cholecystokinin-induced amylase release from rat pancreatic acini , 1992, Regulatory Peptides.

[20]  J. Raufman,et al.  Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. , 1992, The Journal of biological chemistry.

[21]  W. Rutter,et al.  Onset of cell-specific gene expression in the developing mouse pancreas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Eng.  Exendin peptides. , 1992, The Mount Sinai journal of medicine, New York.

[23]  L. Orci,et al.  Embryogenesis of the murine endocrine pancreas; early expression of pancreatic polypeptide gene. , 1991, Development.

[24]  D. Hanahan,et al.  Hybrid insulin genes reveal a developmental lineage for pancreatic endocrine cells and imply a relationship with neurons , 1988, Cell.

[25]  D. Mintz,et al.  Glucagon metabolism in nonhuman primate pregnancy. , 1974, American journal of obstetrics and gynecology.

[26]  W. Rutter,et al.  Early differentiation of glucagon-producing cells in embryonic pancreas: a possible developmental role for glucagon. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. Teramo,et al.  Human placental barrier to 125-I-glucagon early in gestation. , 1972, The Journal of clinical endocrinology and metabolism.

[28]  S. Bloom,et al.  Failure of the human placenta to transfer pancreatic glucagon. , 1972, Biology of the neonate.

[29]  C. Grobstein,et al.  The influence of extra-epithelial factors on the growth of embryonic mouse pancreatic epithelium. , 1968, Experimental cell research.